DGAP-News: novoGI(TM) Announces Licensing Agreement With Unique Surgical Innovations LLC.
(firmenpresse) - novoGI Inc.
15.08.2012 09:20
---------------------------------------------------------------------------
Innovative Surgical Devices to be Developed
ATLANTA, 2012-08-15 09:19 CEST (GLOBE NEWSWIRE) --
novoGI Inc. today announced that it has signed a License agreement with Unique
Surgical Innovations LLC., (USI) for the development of a patented stapleless
low anterior anastomosis solution.
'We look forward to this product's development and success in clinical trials
as a potential replacement for the current method of stapled low anterior
resections,' said Gavriel D. Meron, President and Chief Executive Officer of
novoGI. 'This product is expected to complement the ColonRing, our clinically
proven patented nitinol-based compression anastomosis solution which has been
evidenced for ease of use, better healing processes, and successful outcomes in
regard to leak rates. The combination of an innovative stapleless low anterior
anastomosis solution and our current product can enable us to expand our
offering of a completely stapleless resection and anastomosis procedure for
colorectal surgeons worldwide.'
Mr. Meron continued,' We see this agreement as yet another step towards
expanding our procedure offerings in line with our focus on advancing patient
care and seeking better outcomes through novoGI's comprehensive approach to GI
disease management.'
About novoGI
novoGI is focused on providing an expanding range of solutions for GI disease
management through a globally branded, high quality, market driven company. The
US headquarters are in Atlanta, Georgia; research, development and
manufacturing facilities in Netanya, Israel; and its European headquarters are
near Paris, France.
NOVOGI, the NOVOGI logo, the GI logo, DEFINING THE FUTURE, LARA and the LARA
logo, are trademarks and/or registered trademarks of novoGI Inc.
CONTACT: Marcom(at)novoGI.com
News Source: NASDAQ OMX
15.08.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: novoGI Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US9902064198
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 15.08.2012 - 09:20 Uhr
Sprache: Deutsch
News-ID 174716
Anzahl Zeichen: 1997
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 208 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: novoGI(TM) Announces Licensing Agreement With Unique Surgical Innovations LLC."
steht unter der journalistisch-redaktionellen Verantwortung von
novoGI Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
